DAL
80
-4
TRV
53
-3
QCOM
48
-7
NAVI
41
-3
BAC
50
-3
EFX
32
2
PSA
51
-4
ICE
59
-3
ROK
55
8
M
20
-4
UHS
54
3
PVH
52
-3
XOM
47
5
URI
53
-2
MKC
56
8
NTAP
64
2
COST
58
-2
PX
75
5
DG
2
-6
HUM
48
6
DAL
80
-4
TRV
53
-3
QCOM
48
-7
NAVI
41
-3
BAC
50
-3
EFX
32
2
PSA
51
-4
ICE
59
-3
ROK
55
8
M
20
-4
UHS
54
3
PVH
52
-3
XOM
47
5
URI
53
-2
MKC
56
8
NTAP
64
2
COST
58
-2
PX
75
5
DG
2
-6
HUM
48
6
Financhill
Back

InfuSystems Holdings 10K Form

Buy
67

INFU
InfuSystems Holdings

Last Price:
9.22
Seasonality Move:
7.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INFU News And Ratings

See the #1 stock for the next 7 days that we like better than INFU

INFU Financial Statistics

Sales & Book Value

Annual Sales: $125.79M
Cash Flow: $6.43M
Price / Cash Flow: 78.74
Annual Sales: $2.61
Price / Book: 3.44

Profitability

EPS (TTM): 0.06330
Net Income (TTM): $1.48M
Gross Margin: $63.11M
Return on Equity: 2.8%
Return on Assets: 1.42%

InfuSystems Holdings Earnings Forecast

Key InfuSystems Holdings Financial Ratios

  • The Gross Profit Margin over the past 17 years for INFU is 50.17%.
  • The Selling, General & Administrative Expenses for INFU have been equal to 46.14% of Gross Profit Margin.
  • The Interest Expense is 248.85% of Operating Income.
  • The Net Earning history of INFU is 0.69% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 9 years.

InfuSystems Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: INFU
Website: infusystem.com

Debt

Debt-to-Equity Ratio: 0.5
Current Ratio: 1.98
Quick Ratio: 1.37

Price-to-Earnings

Trailing P/E Ratio: 224.75
Forward P/E Ratio: 44.95

INFU Technical Analysis vs Fundamental Analysis

Buy
67
InfuSystems Holdings (INFU) is a Buy

Is InfuSystems Holdings a Buy or a Sell?